Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geiger, H.
Right arrow Articles by Van Zant, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geiger, H.
Right arrow Articles by Van Zant, G.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Brief Reports
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 July 2002, Vol. 100, No. 2, pp. 721-723

BRIEF REPORT

Analysis of the hematopoietic potential of muscle-derived cells in mice

Hartmut Geiger, Jarrod M. True, Barry Grimes, Elizabeth J. Carroll, Roger A. Fleischman, and Gary Van Zant

From the Departments of Internal Medicine and Physiology, University of Kentucky Medical Center; and the Veterans Administration Hospital, Lexington, KY.


    Abstract
Top
Abstract
Introduction
Study design
Results and discussion
References

Cells in murine muscle have been reported to differentiate into hematopoietic stem and progenitor cells and thus repopulate the hematopoietic system of an irradiated animal. This activity was attributed to muscle stem cells. We used an in vitro and in vivo approach to identify the hematopoietic repopulating activity found in muscle tissue of mice by antibody staining and cell sorting. We confirmed existence of a hematopoietic repopulating cell in muscle tissue, but the data strongly suggest that repopulation is due not to muscle stem cells but to hematopoietic cells present in muscle tissue. Unexpectedly, the blood-forming cells were enriched in muscle relative to their frequency in peripheral blood. (Blood. 2002;100:721-723)

© 2002 by The American Society of Hematology.

    Introduction
Top
Abstract
Introduction
Study design
Results and discussion
References

An emerging theme in stem cell biology is the flexibility or "plasticity" retained by adult stem cells such as hematopoietic and neural stem cells to express differentiation programs appropriate to specific tissue microenvironments.1-3 Plasticity was also ascribed to skeletal muscle stem cells, which were reported to differentiate into hematopoietic stem cells when transplanted into lethally irradiated animals.4-6 To investigate the developmental potential and plasticity of cells in skeletal muscle, we sorted cells derived from murine muscle tissue on the basis of expression of surface markers found on hematopoietic cells, endothelial cells, and muscle stem and progenitor cells. The potential of stem and progenitor cells was analyzed in vitro by using a cobblestone area-forming cell (CAFC) assay originally described for studying hematopoietic cells7 and in vivo by using a transplantation assay.


    Study design
Top
Abstract
Introduction
Study design
Results and discussion
References

Mice

C57BL/6J mice were from The Jackson Laboratory (Bar Harbor, ME). DBA/2CR, C57BL/6CR, and B6.SJL (Ptprca [Ly5.1]) mice were from Charles River Laboratories (Frederick, MD). For CAFC assays, muscle tissue was derived from DBA/2 mice; for transplantation experiments, C57BL/6 and C57BL/6 Ly5.1 mice were used.

Muscle cell preparation

Mice (5-8 weeks of age) were given a perfusion of 20 mL cold phosphate-buffered saline (PBS) at a flow rate of 4 mL/minute. Perfusate was pumped into the left ventricle of the heart and removed by means of the right atrium. The gastrocnemius, soleus, and plantaris muscles were excised and manipulated in further steps on ice in Iscoves modified Dulbecco medium (Life Technologies, Grand Island, NY), 15% fetal-calf serum (FCS; Hyclone Laboratories, Logan, UT), 0.5% chick-embryo extract (Sigma, St Louis, MO), 80 U/mL penicillin (Life Technologies), and 80 mg/mL streptomycin (Life Technologies). Muscle tissue was finely minced into pieces of about 1 mm3, washed, resuspended in collagenase and dispase (0.1 U/mL and 0.8 U/mL in PBS; Roche Molecular Biochemicals, Indianapolis, IN), and incubated for 1.5 to 2 hours at 37°C with gentle agitation. The tissue was then vigorously triturated and successively filtered through cell strainers with a pore size of 70 and 40 µm (BD Biosciences, San Jose, CA). Single cells were collected by centrifugation (400g at 4°C), resuspended, and counted. For flow cytometric analyses, cells were stained with antibodies in ice-cold Hanks medium containing 2% FCS, sorted, and either plated on culture trays or injected into mice.

CAFC assay

The CAFC assay was performed without modification as described previously for assessment of hematopoietic cells.7

Transplantation

Transplant-recipient female mice were given antibiotics in drinking water 1 week before irradiation. The mice received a dose of 9 Gy (11 Gy in 1 experiment) at least 4 hours before transplantation (11 Gy was split into 2 doses). In case of competitive transplantation, the competitor cells were of the same genotype as the recipient.

Flow cytometry

Cell suspensions were stained with antibodies according to standard procedures. The analyses were performed on either a FACS Vantage or FACScan device (BD Biosciences). The following antibodies (all from BD Biosciences) were used: CD5 (53-7.3), B220 (RA3-6B2), Mac-1 (M1/70), CD8a (53-6.7), Gr-1 (RB6-8C5), TER-119, c-Kit (2B8), Sca-1 (E13-161.7), Thy1.2 (30-H12), CD34 (RAM34), and CD31 (Mec13.1).


    Results and discussion
Top
Abstract
Introduction
Study design
Results and discussion
References

The expression patterns of hematopoietic epitopes on muscle-derived cells were analyzed by flow cytometry (Figure 1A). Although the mice were perfused with 10 times their blood volume to remove contaminating peripheral blood, a high percentage of muscle-derived cells expressed hematopoietic cell markers, including CD45 (29%), in agreement with the findings of McKinney-Freeman et al8; and B220 (26%), in contrast to the results of Gussoni et al.4 The high percentage of cells positive for Thy-1.2 (53%), an epitope found mostly on T cells, is intriguing, because few CD8+ cells were detectable.


View larger version (66K):
[in this window]
[in a new window]
 
Figure 1. Stem and progenitor cell potential and the potential to differentiate into hematopoietic cells of cells derived from muscle tissue. (A) Epitopes expressed on cells derived from muscle tissue. The percentages of total cells that stained positive for a given antibody (± SD) are shown. Summarized are results from at least 3 independent cell preparations and stainings per antibody; int. indicates intermediate. (B) Flow cytometry regions that were applied for sorting using antibodies to Sca-1, CD34, CD31, and CD45. (C) CAFC frequency in sorted cell populations derived from muscle tissue and in WBCs. The CAFC assay permits determination of frequencies of cells with proliferation potential at limiting dilution and provides temporal data indicating the hierarchy of stem and progenitor cells because later-developing colonies arise from more primitive cells. CAFC frequencies/100 000 cells (± SEM) from 3 independent analyses are shown. Muscle tissue for these experiments was derived from DBA/2 mice. WBCs (1 × 105) were, after lysis of erythrocytes, derived from approximately 45 µL of blood. (D) Donor chimerism in peripheral blood in recipient mice 12 weeks after transplantation. Preliminary analyses showed a stable engraftment pattern from 3 months to 8 months after transplantation. Mice were given transplants of the same sorted cell populations derived from muscle tissue and from WBCs reported for the CAFC analysis, allowing a direct comparison of the in vitro and in vivo potential of the cells. The percentage of donor-derived cells in peripheral blood (± SEM) is shown. Data are based on at least 2 independent cell sorts and transplantations for each cell population. In each experiment, each sorted cell population was transplanted into at least 2 mice; c.c. indicates 2 × 105 competitor cells.

Next, using a CAFC assay, we tested the in vitro stem and progenitor cell potential of sorted muscle-derived cell populations and determined the frequencies of CAFCs in muscle cell populations positive (+) and negative (-) or intermediate (int) for Sca-1, CD34, CD31, and CD45 and in cells derived from peripheral blood (Figure 1B, C). In all cases, cobblestone areas derived from muscle cells looked similar to cobblestone areas derived from bone marrow (BM).

CD34+ cells, reported to be muscle stem and progenitor cells,9 did not generate cobblestone areas. Embryonic endothelial cells (CD31+) have the potential to differentiate into hematopoietic cells.10 We detected a high frequency of CAFCs in muscle cells positive for CD31. However, because of their low abundance, the CD31+ population accounted for only half of the total number of CAFCs in the muscle-derived cell suspension (data not shown). The remainder of the CAFC-forming activity was found in CD45+ cells. We also noted that the staining and sorting manipulations reduced CAFC activity to almost 25% that in unstained cells. Cells with in vitro myogenic activity were enriched in the CD45- and Thy1.2+ cell populations (data not shown). In summary, muscle-derived CAFCs were B220-, Thy1.2-, Sca1-/int, CD34-, CD31+ and CD31-/int, and CD45+, results indicating a hematopoietic, not a muscle, origin of the cells.

The ability of distinct muscle-derived cell populations to repopulate the hematopoietic system of irradiated mice was analyzed in a transplantation assay (Figure 1D). Cells were sorted according to regions used for the CAFC assays (Figure 1B) and subsequently transplanted into lethally irradiated Ly5.1-Ly5.2 mismatched mice, and in some cases, admixed with recipient-type BM competitor cells.5,11 Mice given transplants of unstained muscle-derived cells showed long-term (> 8 months) multilineage repopulation and chimerism in secondary BM transplants, confirming the presence of stem cell activity (data not shown). Spleen chimerism reflected the percentage found in peripheral blood (Figure 1D), whereas donor chimerism in the thymus and BM was typically 10% to 20% of the percentage observed in the periphery (data not shown). Interestingly, even in mice showing multilineage reconstitution, most donor-derived cells in peripheral blood were Thy-1+, a feature also reported, but not emphasized, by Kawada and Ogawa.12 We detected the same Thy-1 skewing when white blood cells (WBCs) were used as donor cells, in accordance with a previous study of mobilized peripheral blood cells.13

Muscle-derived cells with the ability to repopulate the hematopoietic compartment were Sca-1-/int, CD34-, CD31-/int, and CD45+ (Figure 1D). Thus, except for CD31, cells with in vitro and in vivo stem and progenitor cell activity showed the same pattern of epitope expression. Because staining with the CD31 antibody did not interfere with homing or engraftment of muscle-derived cells (data not shown), masking of functional protein domains by the antibody could not have accounted for the difference between the results of the 2 assays.

Taken together, the Thy-1 skewing characteristic of repopulation from peripheral blood progenitors and the surface phenotype of the repopulating cell indicate a peripheral hematopoietic stem cell as the repopulating unit. This conclusion is in agreement with observations by Kawada and Ogawa12 and McKinney-Freeman et al.8 In contrast to the findings of McKinney-Freeman et al, however, we detected the repopulating activity in the Sca-1-/int population and not in the Sca-1+ population. Because their report does not show the precise position of the sorting region, a direct comparison is not possible.

As shown in Figure 1C and D, peripheral WBCs also contained CAFCs and repopulating activity. Transplantation of 2.5 × 106 muscle-derived cells, the number we obtained on average from a C57BL/6 mouse, resulted in a chimerism of 8% (Figure 1D). This is 16-fold higher than the chimerism obtained with 1.2 × 105 WBCs (0.5%), which correspond to 55 µL of blood. Indeed, to achieve the same percentage of chimerism observed after transplantation of muscle cells derived from a single mouse would require WBCs derived from 900 µL of blood. This suggests that these repopulating cells are not contaminating stem cells found in peripheral blood. Given that we obtained on average 1.8 × 106 muscle-derived cells from a DBA/2 mouse, the CAFC activity in muscle tissue dissected from one animal would be contained in 1.8 mL of blood (Figure 1C).

Thus, we found that skeletal muscle tissue is enriched for hematopoietic stem cells. Further analyses will identify the location of these cells in muscle and determine whether they are sequestered in the wall of the vasculature or within the muscle tissue itself.

Since this manuscript was submitted for publication, McKinney-Freeman et al8 reported that muscle-derived hematopoietic stem cells are hematopoietic of origin, a finding supported by our analyses.


    Footnotes

Submitted November 6, 2001; accepted March 12, 2002.

Supported by National Institutes of Health grant AG16653 (G.V.Z.) and a fellowship of the Deutsche Akademie der Naturforscher Leopoldina funded by the Bundesministerium für Bildung und Forschung (H.G.).

The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.

Reprints: Hartmut Geiger, Division of Hematology/Oncology, Departments of Internal Medicine and Physiology, University of Kentucky Medical Center, 800 Rose Street, Lexington KY, 40536-0093; e-mail: ghart2{at}uky.edu.


    References
Top
Abstract
Introduction
Study design
Results and discussion
References

1. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229-1234[CrossRef][Medline] [Order article via Infotrieve].

2. Clarke DL, Johansson CB, Wilbertz J, et al. Generalized potential of adult neural stem cells. Science. 2000;288:1660-1663[Abstract/Free Full Text].

3. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705[CrossRef][Medline] [Order article via Infotrieve].

4. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 1999;401:390-394[CrossRef][Medline] [Order article via Infotrieve]

5. Jackson KA, Mi T, Goodell MA. Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc Natl Acad Sci U S A. 1999;96:14482-14486[Abstract/Free Full Text].

6. Pang W. Role of muscle-derived cells in hematopoietic reconstitution of irradiated mice. Blood. 2000;95:1106-1108[Free Full Text].

7. de Haan G, Nijhof W, Van Zant G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood. 1997;89:1543-1550[Abstract/Free Full Text].

8. McKinney-Freeman SL, Jackson KA, Camargo FD, Ferrari G, Mavilio F, Goodell MA. Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci U S A. 2002;99:1341-1346[Abstract/Free Full Text].

9. Beauchamp JR, Heslop L, Yu DS, et al. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol. 2000;151:1221-1234[Abstract/Free Full Text].

10. Nishikawa SI, Nishikawa S, Kawamoto H, et al. In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos. Immunity. 1998;8:761-769[CrossRef][Medline] [Order article via Infotrieve].

11. Harrison DE, Jordan CT, Zhong RK, Astle CM. Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp Hematol. 1993;21:206-219[Medline] [Order article via Infotrieve].

12. Kawada H, Ogawa M. Bone marrow origin of hematopoietic progenitors and stem cells in murine muscle. Blood. 2001;98:2008-2013[Abstract/Free Full Text].

13. Szilvassy SJ, Meyerrose TE, Ragland PL, Grimes B. Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood. 2001;98:2108-2115[Abstract/Free Full Text].

© 2002 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
H. Xu, S. Eleswarapu, H. Geiger, K. Szczur, D. Daria, Y. Zheng, J. Settleman, E. F. Srour, D. A. Williams, and M.-D. Filippi
Loss of the Rho GTPase activating protein p190-B enhances hematopoietic stem cell engraftment potential
Blood, October 22, 2009; 114(17): 3557 - 3566.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Kohler, V. Schmithorst, M.-D. Filippi, M. A. Ryan, D. Daria, M. Gunzer, and H. Geiger
Altered cellular dynamics and endosteal location of aged early hematopoietic progenitor cells revealed by time-lapse intravital imaging in long bones
Blood, July 9, 2009; 114(2): 290 - 298.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Z. Xing, M. A. Ryan, D. Daria, K. J. Nattamai, G. Van Zant, L. Wang, Y. Zheng, and H. Geiger
Increased hematopoietic stem cell mobilization in aged mice
Blood, October 1, 2006; 108(7): 2190 - 2197.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Rosu-Myles, E. Stewart, J. Trowbridge, C. Y. Ito, P. Zandstra, and M. Bhatia
A unique population of bone marrow cells migrates to skeletal muscle via hepatocyte growth factor/c-met axis
J. Cell Sci., October 1, 2005; 118(19): 4343 - 4352.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geiger, H.
Right arrow Articles by Van Zant, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geiger, H.
Right arrow Articles by Van Zant, G.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Brief Reports
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020